Hepatitis C virus (HCV) is an important human pathogen that can cause acute and chronic hepatitis, liver cirrhosis and, possibly, hepatocellular carcinoma. This virus accounts for up to 25% of community- acquired hepatitis and over 90% of transfusion-associated hepatitis in the United States. The virus particles contain a positive polarity, single-stranded RNA genome with 5' and 3' noncoding (NC) regions. The core (C), envelope 1 (E1) and envelope 2 (E2) proteins are encoded at the 5' terminus and the nonstructural proteins are encoded at the 3' terminus of the single open reading frame of the genome. Furthermore, the finding of genetic heterogeneity of the HCV genome, especially in the genes encoding the envelope proteins, suggests that there may be heterogeneity similar to that seen in the envelope gene of human immunodeficiency viruses. Such a finding would bode ill for attempts at vaccine development. In this project we have extended our previous sequence analysis of the viral genome to include the core gene, which is the most conserved HCV gene. The phylogenetic analysis of this gene was in agreement with that of the envelope 1 gene, which is highly variable. Additional analysis identified conserved features of the core gene that will be useful in understanding the role of the nucleocapsid protein in viral replication. Other major findings were: (i) identification of HCV RNA in dialysis patients; (ii) prevention of HCV infection in chimpanzees following antibody-mediated neutralization in vitro; and (iii) establishment and characterization of antibody-free prototype strains of the different genotypes of HCV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000570-05
Application #
3746587
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Kyuregyan, Karen K; Poleschuk, Valentina F; Zamyatina, Natalya A et al. (2005) Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein. Virus Res 114:154-7
Meunier, Jean-Christophe; Engle, Ronald E; Faulk, Kristina et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102:4560-5
Bukh, Jens (2004) A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39:1469-75
Nam, Jae-Hwan; Faulk, Kristina; Engle, Ronald E et al. (2004) In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin. J Virol 78:9389-99
Bukh, Jens; Christensen, Erik; Krogsgaard, Kim (2003) [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology] Ugeskr Laeger 165:1233
Sakai, Akito; Claire, Marisa St; Faulk, Kristina et al. (2003) The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A 100:11646-51
Bartosch, Birke; Bukh, Jens; Meunier, Jean-Christophe et al. (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100:14199-204
Corbet, Sylvie; Bukh, Jens; Heinsen, Anja et al. (2003) Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 41:1091-100
Bukh, Jens; Pietschmann, Thomas; Lohmann, Volker et al. (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 99:14416-21
Ma, Xiaoying; Forns, Xavier; Gutierrez, Robin et al. (2002) DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice. Vaccine 20:3263-71

Showing the most recent 10 out of 21 publications